Dosing study of remifentanil and propofol for tracheal intubation without the use of muscle relaxants

Sixty ASA I and II patients, premedicated with midazolam, were administered propofol 2 mg.kg−1 and remifentanil 3 μg.kg−1 (group R3), remifentanil 4 μg.kg−1 (group R4) and remifentanil 5 μg.kg−1 (group R5). Laryngoscopy and intubation were performed 1 min after the administration of the study drugs and the intubating conditions were assessed. Good to excellent conditions were observed in 12 patients in group R3 compared with 19 patients each in groups R4 and R5 (p = 0.004). Significant reductions in mean arterial pressure (MAP) and heart rate (HR) after administration of the study drug were observed in each group, p < 0.01. There was, however, no difference in mean MAP and HR between the three groups at all time points. We conclude that remifentanil 4–5 μg.kg−1 may reliably provide good to excellent conditions for tracheal intubation when administered after propofol 2 mg.kg−1.

[1]  N. T. Smith,et al.  Pretreatment with Sedative-Hypnotics, but Not with Nondepolarizing Muscle Relaxants, Attenuates Alfentanil-Induced Muscle Rigidity , 1995 .

[2]  P. White,et al.  Use of mivacurium during laparoscopic surgery: effect of reversal drugs on postoperative recovery. , 1994, Anesthesia and analgesia.

[3]  Stuart A. Grant,et al.  Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil. , 1998, British journal of anaesthesia.

[4]  J. Stevens,et al.  Tracheal Intubation in Ambulatory Surgery Patients: Using Remifentanil and Propofol Without Muscle Relaxants , 1998, Anesthesia and analgesia.

[5]  N. T. Smith,et al.  Physiology of Alfentanil‐induced Rigidity , 1986, Anesthesiology.

[6]  D. Mulholland,et al.  Intubation with propofol augmented with intravenous lignocaine , 1991, Anaesthesia.

[7]  David J. Hermann,et al.  The Pharmacokinetics of the New Short‐acting Opioid Remifentanil (GI87084B) in Healthy Adult Male Volunteers , 1993, Anesthesiology.

[8]  E. Kharasch,et al.  The Role of Cytochrome P450 3A4 in Alfentanil Clearance: Implications for Interindividual Variability in Disposition and Perioperative Drug Interactions , 1997, Anesthesiology.

[9]  J. Keaveny,et al.  Intubation under induction doses of propofol , 1988, Anaesthesia.

[10]  J. Russell,et al.  Effect of remifentanil on the haemodynamic response to orotracheal intubation. , 1998, British journal of anaesthesia.

[11]  P. Glass,et al.  Measured Context‐sensitive Half‐times of Remifentanil and Alfentanil , 1995, Anesthesiology.

[12]  Difficult tracheal intubation: a retrospective study , 1987 .

[13]  S L Shafer,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil: II. Model Application , 1997, Anesthesiology.

[14]  Thomas W. Schnider,et al.  Pharmacokinetics and Pharmacodynamics of Remifentanil , 1997 .

[15]  R. Miguel,et al.  A Multicenter Evaluation of Total Intravenous Anesthesia with Remifentanil and Propofol for Elective Inpatient Surgery , 1996, Anesthesia and analgesia.

[16]  M. Weinger,et al.  Pretreatment with sedative-hypnotics, but not with nondepolarizing muscle relaxants, attenuates alfentanil-induced muscle rigidity. , 1994, Journal of clinical anesthesia.

[17]  J. R. Young,et al.  Difficult tracheal intubation: a retrospective study , 1987, Anaesthesia.

[18]  P. Glass,et al.  Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra‐Short‐Acting Opioid: Remifentanil (GI87084B) , 1993, Anesthesia and analgesia.